Download Free Medical Neurogenic Voice Disorders PowerPoint Presentation

Neurogenic Voice Disorders PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical presentation on Speech and Voice Disorders, which is titled "Neurogenic Voice Disorders", to know about neurogenic voice disorders.

Tags : Speech, Voice Disorders, Neurogenic

Published on : Jul 12, 2021 | Views : 2015 | Downloads : 1

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Neurogenic Voice Disorders Courtney Lippe Kristina Curro
Slide 2-

Organic Voice Disorders Structural: involve something physically wrong with a speech mechanism. Neurogenic: are caused by a problem with the CNS or PNS.
Slide 3-

Spasmodic Dysphonia “SD is characterized by abnormal involuntary movements that are action induced and task specific” Stemple et al. Movement during vocalization that produces involuntary co-contraction of the muscles used to produce sound. Normal structure!
Slide 4-

Spasmodic Dysphonia 3 types : Adductor vs. Abductor and rare form of mixed dysphonia Recent evidence suggest that it is a focal dystonia of the CNS Extrapyramidal in origin Supranuclear lesion locus in area of the Basal Ganglia
Slide 5-

Spasmodic Dysphonia: Complaints Poor vocal quality Loss of vocal control Rapid fatigue and strain involved in speech Cannot be understood due to decrease in intelligibility
Slide 6-

Spasmodic Dysphonia Diane Rehm NPR talk radio voice
Slide 7-

Spasmodic Dysphonia Treatments: Midline type 2 Thyroplasty (surgical) Sectioning or removal of the recurrent laryngeal nerve (surgical) Botox injection Chiropractics (derotation of 1st and 2nd vertebrae) Behavioral therapy
Slide 8-

Midline type 2 Thyroplasty
Slide 9-

ppt slide no 9 content not found
Slide 10-

Benign Essential Tremor Neurologic movement disorder that primarily involve upper body and limbs but can also involve head, voice, tongue or palate Not related to any other disease process Usually absent at rest Average age of onset 45 years
Slide 11-

Benign Essential Tremor Katherine Hepburn
Slide 12-

Benign Essential Tremor : Complaints Poor vocal quality “old sounding voice” Decrease in volume Fatigue with vocal use
Slide 13-

Benign Essential Tremor : Team: neurologist, otolaryngologist and speech Language Pathologist There is no cure for organic voice tremor but the symptoms can be treated. Botox is an option if there is co-occuring spasticity Speech therapy to improve respiratory support Prognosis: poor
Slide 14-

Current Therapy : Beta-adrenergic blockers(medication) Primidone(medication) Benzodiazepines(medication) Botulinum A(injections) Alcohol Thalamotomy(surgical) Thalamic Stimulation(surgical) Non-Pharmacologic Treatment
Slide 15-

Neurogenic Vocal Fold Paralysis Figure 5. Unilateral vocal cord paralysis. (Left) Larynx in abduction. (Right) Larynx in adduction, showing paralyzed vocal cord (arrow).
Slide 16-

Vocal Fold Paralysis: Nerve impulses to the vocal folds are either partially or completely interrupted which results in limited or no movement of the muscles of the larynx. Can occur at any age Results: Voice changes, problems with airway, dysphagia
Slide 17-

Complaints: Hoarseness Breathy Diplophonia Shortness of breath Stridor Ineffective cough Coughing or choking with food globus sensation
Slide 18-

Neurologic Causes: Arnold-Chiari malformation Meningomyelocele Diabetes mellitus Amyotrophic lateral sclerosis Myasthenia Gravis Mobius syndrome Charcot-Marie-Tooth syndrome Postpolio syndrome Lyme Disease
Slide 19-

Medical Therapy: Corticosteroids work for some conditions Glucose management for diabetes Reflux medication
Slide 20-

Parkinsons’s Disease/Parkinsonism/resulting in Hypokinetic Dysarthria Cause/Site of lesion: Degeneration of the substantia nigra, causing a decrease in the amount of dopamine in the brain and thereby inhibiting movement. Drug-induced, such as exposure to heroin Post-encephalitic, thought to be due to exposure to a virus, although evidence is weak at best. Idiopathic, possibly due to the aging process or heredity.
Slide 21-

Vocal quality complaints: Hard to get speech started Quiet or weak voice Fatigue during speech Reports “stuttering”, or repeating sounds or words.
Slide 22-

Hypokinetic dysarthria voice characteristics (Duffy, 2005):
Slide 23-

Phonation Mono-pitch Mono-loudness Harsh Voice Quality Breathy voice Low pitch (reduced f0) Reduced intensity Voice tremor Increased jitter/shimmer
Slide 24-

Respiration: Reduced maximum vowel prolongation Reduced airflow Reduced respiratory excursions Reduced vital capacity Paradoxical respiratory movements
Slide 25-

Articulation/Prosody: Reduces Stress Imprecise Consonants Variable Rate Repeated phonemes Inappropriate pauses Continued voicing during voiceless consonants
Slide 26-

Resonance: Increased nasalization is possible, but usually normal.
Slide 27-

Laryngeal Characteristics: Bowed vocal folds despite solid, non-flaccid appearance Tremulousness of arytenoid cartilages Asymmetry of structure movement
Slide 28-

Treatment options and effectiveness LSVT to promote volume and breath support (Ramig and Verdolini, 1996) Prosodic exercises (as reported in Scott and Caird, 1983, from Ramig and Verdolini, 1996)
Slide 29-

Drug Treatment Most drug treatment is for PD in general, not specifically for treatment of the voice disorder itself. levodopa-carbidopa (dopamine precursors), bromocriptine (dopamine agonist) etc. (Kolb and Wishaw, 1996)
Slide 30-

Surgical Treatment: Collagen injection into vocal folds (Sewall et al. 2006) to improve glottal closure. Pt. subjectively reported improvement of vocal quality (Vocal Handicap Index), and objective CAPE-V measurements also showed improvement. However, small sample size and short duration of monitoring. Deep brain stimulation and fetal cell transplantation were shown to help reduce overall symptoms of PD, but had a negative impact on speech quality (Trail et al. 2005)
Slide 31-

Other Treatments: Transcranial Magnetic Stimulation (Dias et al., 2006) showed that stimulating the primary motor cortex (M1)-mouth area provided objective and subjective improvements in speech and may be used in future treatment.
Slide 32-

Prognosis: New research suggests a combination of LSVT and collagen injections may provide the greatest improvement to voice quality.
Slide 33-

Flaccid Dysarthria Cause/Site of lesion: Lower motor neuron involvement. In Myasthenia Gravis (MG): Failure of neuromuscular transmission wherein acetylcholine degrades too quickly because the immune system attacks its own AchRs. This lack of Ach reaching the neuronal terminals causes flaccid dysarthria that recovers after a period of rest.
Slide 34-

Complaints: Breathy or quiet voice, inability to move articulators In MG: Weakness and fatigue after muscle use, for example, weakness increases towards the end of a conversation, and recovers with a period of rest
Slide 35-

Phonation: Breathiness Short phrases Audible inspiration
Slide 36-

Respiration: Insufficient breath support, although isolated respiration difficulty is rare. Poor posture Reduced exhalation control Slow breathing
Slide 37-

Articulation/Prosody Harsh voice Monoloudness Monopitch
Slide 38-

Resonance: Imprecise consonants (although this occurs with may other dysarthrias) Increased nasalization and nasal emission (may be the first sign of ALS)
Slide 39-

Treatment options and effectiveness: MG: General treatment includes thymectomy to reduce antibody formation, but it’s effect on voice treatment specifically is not addressed. Thyroplasty: surgery to enhance function of the larynx Palatal lifts if the velum is affected
Slide 40-

Ataxic dysarthria Location/site of lesion: bilateral cerebellar involvement Complaints of patient: imprecise articulation, laborious speech, may be observed groping for sounds, sound substitution
Slide 41-

Phonation: Breathy Hoarse Tremor Mono-pitch Mono-loudness
Slide 42-

Respiration: Shallow inhalation and reduced exhalation control Rapid breaths Irregular and suddenly forced patterns
Slide 43-

Articultion/Prosody Imprecise, slow and irregular Explosive syllable stress Explosive loudness, outbursts Abnormal prolongations of phonemes
Slide 44-

Treatment options and effectiveness: Intense phonomotor treatment (Kendall et al. 2006): in a single case study found that intense phonomotor treatment increased ease of production of single sounds but generalization to connected speech did not occur.
Slide 45-

References Cannito, Michael P. et al. Perceptual Analysis of Spasmodic Dysphonia Before and After. Arch Otolaryngol Head Neck Surg.,130:1393-1399 Daya, Hamid FRCS et al.(2006) Pediatric Vocal Fold Paralysis. Arch Otolaryngol Head Neck Surg.,vol 126:21-25 Dias, A.E., Barbosa, E.R., Coracini, K., Maia, F., Marcolin, M. A., Fregni, F. (2006). “Effects of repetitive transcranial magnetic stimulation on voice and speech in Parkinson's disease.” Acta Neurologica Scandinavica. 113(2), 92-99 Duffy, J.R. (2005). Motor Speech Disorders: Substrates, Differential Diagnosis, and Management. Elsevier Mosby : St. Louis. Dworkin, J.P. (1991). Motor Speech Disorders. Mosby: New York. Dysphonia by Surgical Myectomy : A Preliminary Report. Annals of Otology, Rhinology & Laryngology. 115(2):97-102, 2006.
Slide 46-

References Kendall, D.L., Rodriguez A.D., Rosenbek, J.C., Conway T., Gonzalez Rothi L.J.“Influence of intensive phonomotor rehabilitation on apraxia of speech.” Journal of Rehabilitation Research and Development. 43(3). 409-18 Kolb, B., Wishaw, I.Q. (1996). Fundamentals of Human Neuropsychology – 4th Edition. W.H. Freeman Company : New York. Neurogenic dysphonia (1994). Ann Otol Rhinol Laryngol. Jan-Feb;93(1 Pt 1):57-64. PMID: 6703599 [PubMed - indexed for MEDLINE] Rajish, Pahwa. (2003) “Essential Tremor: differential diagnosis and current therapy”. The American Journal of Medicine. 115(2), 134-142
Slide 47-

References Ramig, L.O., Verdolini, K. (1998). “Treatment Efficacy, Voice Disorders”. Journal of Speech, Language, and Hearing Research. 41(1), S101 – S116. Sapienza CM, Murry T, Brown WS (1998) Variations in adductor spasmodic dysphonia: Acoustic evidence. J Voice, 12(2): 214-222 Stemple, J.C., Glaze, L.E., Klaben, B.G. (2000). Clinical Voice Pathology- Third Edition. Singular Publishing Group: Canada. Sewall G.K., Jiang J., Ford C.N. (2006). “Clinical evaluation of Parkinson’s –related dysphonia”. Laryngoscope. Oct;116(10):1740-4 Trail, M., Fox, C., Ramig, L.O., Sapire, S., Howard, J, and Lai, E.C. (2005). “Speech treatment for Parkinson’s Disease”. NeuroRehabilitation. 20, 205–221. http://www.parkinsonsdisease-rhodeisland.org/Treating%20the%20voice.htm as retrieved on 3/1/2007.